What is the best course of action for a female patient experiencing recurrent bloody noses (epistaxis) and migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of Recurrent Epistaxis with Migraines

Primary Recommendation

This patient requires systematic evaluation with anterior rhinoscopy to identify the bleeding site, aggressive nasal moisturization, and screening for hereditary hemorrhagic telangiectasia (HHT), while the migraines should be managed independently as they are likely coincidental rather than causally related. 1, 2

Understanding the Clinical Presentation

Epistaxis-Migraine Association

  • The co-occurrence of epistaxis and migraine is uncommon but documented, with epistaxis typically occurring at the peak of headache followed by symptom resolution due to trigeminovascular system activation causing dilation of external and internal carotid arteries. 3
  • However, most cases of recurrent epistaxis and migraine represent two separate common conditions occurring in the same patient rather than a unified pathophysiologic process. 1, 2

Critical Red Flag: Hereditary Hemorrhagic Telangiectasia

  • HHT affects 1 in 5,000-18,000 individuals and is frequently underdiagnosed, with nosebleeds occurring in >90% of patients and often increasing with age. 1
  • The American Academy of Otolaryngology-Head and Neck Surgery recommends assessing for HHT in any patient with recurrent nosebleeds, particularly with family history of recurrent nosebleeds or visible telangiectasias. 1, 2
  • Early HHT diagnosis allows for systemic screening of arteriovenous malformations in other organs and prevents life-threatening complications. 1

Immediate Diagnostic Approach

Essential Examination Steps

  • Perform anterior rhinoscopy after removing blood clots to identify the bleeding site, which will be visible in 87-93% of anterior epistaxis cases. 1, 4
  • Examine for visible nasal and oral mucosal telangiectasias during the physical examination. 2
  • Document specific factors: anticoagulant/antiplatelet use, intranasal medication use (especially topical corticosteroids or decongestant overuse), family history of recurrent nosebleeds, and environmental factors (dry bedroom air, mouth breathing, CPAP use). 1, 2

When to Perform Nasal Endoscopy

  • Nasal endoscopy is indicated if bleeding recurs despite appropriate cautery and preventive measures, as this may indicate unrecognized pathology requiring specialist evaluation. 1, 4
  • The American Academy of Otolaryngology-Head and Neck Surgery recommends nasal endoscopy for recurrent epistaxis to exclude serious pathology such as tumors or foreign bodies. 2

Treatment Protocol for Epistaxis

Acute Management

  • Apply topical anesthesia (lidocaine or tetracaine) followed by targeted cauterization restricted only to the active bleeding site. 1
  • Electrocautery is more effective with fewer recurrences (14.5%) compared to chemical cauterization (35.1%) when an anterior bleeding site is identified. 4, 5
  • Avoid bilateral simultaneous septal cautery as it increases the risk of septal perforation. 4

Prevention of Recurrence (Most Critical)

  • Prescribe petroleum jelly or nasal saline gel to be applied to the anterior nasal septum 1-3 times daily, particularly before bedtime—this is the cornerstone of prevention for recurrent epistaxis. 1, 2
  • Recommend bedside humidifier use to address overnight mucosal drying, which is the most common cause of recurrent morning epistaxis. 1
  • Regular use of saline sprays throughout the day keeps nasal mucosa moist. 4

Medication Review

  • Discontinue intranasal corticosteroids if currently in use, as they increase epistaxis risk with a relative risk of 2.74 (range 1.88-4.00). 2
  • Do not routinely discontinue anticoagulants or antiplatelet medications for epistaxis alone, as most cases resolve with local measures and the thrombotic risk carries higher morbidity and mortality than epistaxis itself. 2

Migraine Management

Independent Treatment Approach

  • Treat the migraines as a separate condition using standard migraine management protocols. 6, 7
  • Educate the patient to treat migraine attacks early when symptoms "whisper migraine" rather than waiting until they "shout migraine," as early treatment is more effective with lower rates of adverse events and recurrence. 6
  • Consider migraine prophylaxis if attacks are frequent or disabling. 3

Rare Exception: True Epistaxis-Migraine Syndrome

  • In the unusual case where epistaxis consistently occurs at the peak of headache and is followed by complete headache resolution, this may represent true trigeminovascular-mediated epistaxis. 3
  • If intracranial hypertension is suspected (based on additional symptoms like visual changes, pulsatile tinnitus, or radiological findings), acetazolamide may address both the epistaxis and headache. 8

Critical Pitfalls to Avoid

  • Do not dismiss recurrent epistaxis as "just dry air" without performing anterior rhinoscopy to identify the bleeding site. 1
  • Do not overlook HHT screening, as delayed diagnosis prevents timely screening for systemic arteriovenous malformations. 1
  • Do not assume the epistaxis and migraines are causally related without evidence of the specific temporal pattern (epistaxis at headache peak followed by resolution). 3
  • Do not order routine imaging for headache alone unless there are true red flag features (new neurologic deficits, sudden onset "thunderclap" pattern, or significant change in headache character). 7

When to Refer to Otolaryngology

  • Immediate referral is warranted if HHT is suspected based on family history, visible telangiectasias, or recurrent bilateral epistaxis. 1
  • Refer if bleeding recurs despite appropriate cautery and preventive measures, as this requires nasal endoscopy to evaluate for unrecognized pathology. 1, 4
  • Consider referral if bleeding persists despite local measures and requires evaluation for surgical arterial ligation or endovascular embolization. 4, 2

References

Guideline

Recurrent Morning Epistaxis Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Recurrent Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Research

Recurrent epistaxis following stabbing headache responsive to acetazolamide.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.